HRMY - Harmony Biosciences Holdings - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart

HRMY is currently covered by 9 analysts with an average price target of $45.44. This is a potential upside of $12.85 (39.43%) from yesterday's end of day stock price of $32.59.

Harmony Biosciences Holdings's activity chart (see below) currently has 200 price targets and 179 ratings on display. The stock rating distribution of HRMY is 76.92% BUY, 19.23% HOLD and 3.85% SELL.

Stock Analyst Price Targets - Review

Analysts' price targets on this stock were met 35.95% of the time, taking 136.14 days on average.

Highest price target for HRMY is $72, Lowest price target is $28, average price target is $45.44.

Most recent stock forecast was given by PATRICK TRUCCHIO from HC WAINWRIGHT on 12-Nov-2026. First documented stock forecast 13-Sep-2020.

Currently out of the existing stock ratings of HRMY, 20 are a BUY (76.92%), 5 are a HOLD (19.23%), 1 are a SELL (3.85%).

Split History since 2000:

12/5/00 3 for 1

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 17-Dec-2024

$55

$22.41 (68.76%)

$55

10 days ago
(12-Nov-2026)

0/17 (0%)

$21.2 (62.72%)

Buy Since 22-Sep-2021

$50

$17.41 (53.42%)

$50

1 months 3 days ago
(19-Oct-2026)

6/36 (16.67%)

$12.46 (33.19%)

319

Hold Since 08-May-2026

$34

$1.41 (4.33%)

$29

3 months 17 days ago
(05-Aug-2026)

9/14 (64.29%)

$-4.24 (-11.09%)

142

Buy Since 01-Sep-2022

$51

$18.41 (56.49%)

$46

3 months 22 days ago
(31-Jul-2026)

17/34 (50%)

$15.76 (44.72%)

276

Hold Since 25-Feb-2026

$36

$3.41 (10.46%)

$30

4 months 23 days ago
(30-Jun-2026)

4/9 (44.44%)

$-0.41 (-1.13%)

46

Show more analysts

Please expand the browser size to see the chart

What is HRMY (Harmony Biosciences Holdings) average time for price targets to be met?

On average it took 136 days for the stock forecasts to be reached, with an average price target met ratio of 35.95%.

Which analyst most recently updated their price target on HRMY (Harmony Biosciences Holdings)?

Patrick Trucchio

Which analyst has the most public recommendations on HRMY (Harmony Biosciences Holdings)?

Patrick Trucchio works at HC WAINWRIGHT and has 12 price targets and 17 ratings on HRMY

Which analyst is the currently most bullish on HRMY (Harmony Biosciences Holdings)?

Andreas Argyrides with the highest potential upside of $39.41

Which analyst is the currently most reserved on HRMY (Harmony Biosciences Holdings)?

Jason Gerberry with the lowest potential downside of -$4.59
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?